Bradykinin is one of these substrates and is involved in tissue injury and inflammation, as well as potentially influencing the tumour microenvironment, so increased levels, due to inhibition of ACE, may therefore play a role in tumorigenesis (43). The gene discussed is KNG1; the disease is neoplasm.